MENINGIOMA
Clinical trials for MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA trials appear
Sign up with your email to follow new studies for MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain scan dye tested as safer alternative
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
Brain scan breakthrough: same accuracy with 84% less dye?
Diagnosis CompletedThis study tested whether a special type of MRI scan could detect a common brain tumor called a meningioma using a much smaller dose of contrast dye. Researchers compared new scanning techniques using only one-sixth of the standard dye dose against the current best method in 514 …
Matched conditions: MENINGIOMA
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
Sleep help for brain tumor patients: new therapy trial
Symptom relief CompletedThis study tested whether a talk therapy program for insomnia (CBT-I) is practical and helpful for people with primary brain tumors who have trouble sleeping. Researchers worked with 70 participants to see if they could successfully recruit people, deliver the therapy online, and…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Feb 25, 2026 15:07 UTC
-
Scientists test DNA blueprint method to find better treatments for kids with tough cancers
Knowledge-focused CompletedThis study tested whether doctors could quickly analyze the genetic makeup of a child's tumor and use that information to choose a personalized treatment plan. It involved 186 children and young adults (up to age 21) whose cancers had returned or did not respond to standard treat…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: Giselle Sholler • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC